Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission

Virology

Volumn 400, Issue 2, 2010, Pages 164-174

  Zhang, Hong ^a,b   Rola, Marzena ^a,b   West, John T ^c   Tully, Damien C ^a,b   Kubis, Piotr ^a,b   He, Jun ^a,b   Kankasa, Chipepo ^d   Wood, Charles ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

Autologous or heterologous antibodies; Envelope glycoproteins; Envelope processing and incorporation; HIV 1 subtype C; Neutralization; Perinatal transmission

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MATERNAL PLASMA; NONHUMAN; PERINATAL INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; VERTICAL TRANSMISSION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ANTIBODIES, NEUTRALIZING; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENOTYPE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949571338     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.12.019     Document Type: Article

References (42)

1. Abebe A., Demissie D., Goudsmit J., Brouwer M., Kuiken C.L., Pollakis G., Schuitemaker H., Fontanet A.L., Rinke de Wit T.F. HIV-1 subtype C syncytium-and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999, 13(11):1305-1311.
2. Abraha A., Nankya I.L., Gibson R., Demers K., Tebit D.M., Johnston E., Katzenstein D., Siddiqui A., Herrera C., Fischetti L., Shattock R.J., Arts E.J. CCR5-and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J. Virol. 2009, 83(11):5592-5605.
3. Ahmad N., Baroudy B.M., Baker R.C., Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 1995, 69(2):1001-1012.
4. Ball S.C., Abraha A., Collins K.R., Marozsan A.J., Baird H., Quinones-Mateu M.E., Penn-Nicholson A., Murray M., Richard N., Lobritz M., Zimmerman P.A., Kawamura T., Blauvelt A., Arts E.J. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J. Virol. 2003, 77(2):1021-1038.
5. Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., Stiegler G., Kunert R., Zolla-Pazner S., Katinger H., Petropoulos C.J., Burton D.R. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 2004, 78(23):13232-13252.
6. Bjorndal A., Sonnerborg A., Tscherning C., Albert J., Fenyo E.M. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retrovir. 1999, 15(7):647-653.
7. Bures R., Morris L., Williamson C., Ramjee G., Deers M., Fiscus S.A., Abdool-Karim S., Montefiori D.C. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J. Virol. 2002, 76(5):2233-2244.
8. Burton D.R., Barbas C.F., Persson M.A., Koenig S., Chanock R.M., Lerner R.A. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(22):10134-10137.
9. Burton D.R., Pyati J., Koduri R., Sharp S.J., Thornton G.B., Parren P.W., Sawyer L.S., Hendry R.M., Dunlop N., Nara P.L., et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994, 266(5187):1024-1027.
10. Cheng-Mayer C., Brown A., Harouse J., Luciw P.A., Mayer A.J. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 1999, 73(7):5294-5300.
11. Chohan B., Lang D., Sagar M., Korber B., Lavreys L., Richardson B., Overbaugh J. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 2005, 79(10):6528-6531.
12. Cilliers T., Nhlapo J., Coetzer M., Orlovic D., Ketas T., Olson W.C., Moore J.P., Trkola A., Morris L. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 2003, 77(7):4449-4456.
13. Derdeyn C.A., Hunter E. Viral characteristics of transmitted HIV. Curr. Opin. HIV AIDS 2008, 3(1):16-21.
14. Derdeyn C.A., Decker J.M., Bibollet-Ruche F., Mokili J.L., Muldoon M., Denham S.A., Heil M.L., Kasolo F., Musonda R., Hahn B.H., Shaw G.M., Korber B.T., Allen S., Hunter E. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004, 303(5666):2019-2022.
15. Dickover R.E., Garratty E.M., Plaeger S., Bryson Y.J. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J. Virol. 2001, 75(5):2194-2203.
16. Dickover R., Garratty E., Yusim K., Miller C., Korber B., Bryson Y. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J. Virol. 2006, 80(13):6525-6533.
17. Dubay J.W., Dubay S.R., Shin H.J., Hunter E. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 1995, 69(8):4675-4682.
18. Frost S.D., Liu Y., Pond S.L., Chappey C., Wrin T., Petropoulos C.J., Little S.J., Richman D.D. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J. Virol. 2005, 79(10):6523-6527.
19. Frost S.D., Wrin T., Smith D.M., Kosakovsky Pond S.L., Liu Y., Paxinos E., Chappey C., Galovich J., Beauchaine J., Petropoulos C.J., Little S.J., Richman D.D. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(51):18514-18519.
20. Gray E.S., Meyers T., Gray G., Montefiori D.C., Morris L. Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B. PLoS Med. 2006, 3(7):e255.
21. Haaland R.E., Hawkins P.A., Salazar-Gonzalez J., Johnson A., Tichacek A., Karita E., Manigart O., Mulenga J., Keele B.F., Shaw G.M., Hahn B.H., Allen S.A., Derdeyn C.A., Hunter E. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 2009, 5(1):e1000274.
22. Kliks S.C., Wara D.W., Landers D.V., Levy J.A. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994, 272(6):467-474.
23. Kong X., West J.T., Zhang H., Shea D.M., M'Soka T.J., Wood C. The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J. Virol. 2008, 82(23):11609-11618.
24. Kulkarni S.S., Lapedes A., Tang H., Gnanakaran S., Daniels M.G., Zhang M., Bhattacharya T., Li M., Polonis V.R., McCutchan F.E., Morris L., Ellenberger D., Butera S.T., Bollinger R.C., Korber B.T., Paranjape R.S., Montefiori D.C. Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India. Virology 2009, 385(2):505-520.
25. Li M., Salazar-Gonzalez J.F., Derdeyn C.A., Morris L., Williamson C., Robinson J.E., Decker J.M., Li Y., Salazar M.G., Polonis V.R., Mlisana K., Karim S.A., Hong K., Greene K.M., Bilska M., Zhou J., Allen S., Chomba E., Mulenga J., Vwalika C., Gao F., Zhang M., Korber B.T., Hunter E., Hahn B.H., Montefiori D.C. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 2006, 80(23):11776-11790.
26. Luzuriaga K., Sullivan J.L. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev. 2002, 4(1):21-26.
27. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., Goulder P. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 2006, 80(7):3617-3623.
28. Montefiori D.C. Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays. Current. Protocols. in. Immunology. 2004, John Wiley and Sons, New York, N.Y. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, W. Strober, R. Coico (Eds.).
29. Ndung'u T., Renjifo B., Essex M. Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone. J. Virol. 2001, 75(11):4964-4972.
30. Neilson J.R., John G.C., Carr J.K., Lewis P., Kreiss J.K., Jackson S., Nduati R.W., Mbori-Ngacha D., Panteleeff D.D., Bodrug S., Giachetti C., Bott M.A., Richardson B.A., Bwayo J., Ndinya-Achola J., Overbaugh J. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J. Virol. 1999, 73(5):4393-4403.
31. Rainwater S.M., Wu X., Nduati R., Nedellec R., Mosier D., John-Stewart G., Mbori-Ngacha D., Overbaugh J. Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr. HIV Res. 2007, 5(2):189-197.
32. Roben P., Moore J.P., Thali M., Sodroski J., Barbas C.F., Burton D.R. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 1994, 68(8):4821-4828.
33. Rong R., Gnanakaran S., Decker J.M., Bibollet-Ruche F., Taylor J., Sfakianos J.N., Mokili J.L., Muldoon M., Mulenga J., Allen S., Hahn B.H., Shaw G.M., Blackwell J.L., Korber B.T., Hunter E., Derdeyn C.A. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J. Virol. 2007, 81(11):5658-5668.
34. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyo E.M. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 1993, 168(1):207-210.
35. Scarlatti G., Leitner T., Halapi E., Wahlberg J., Marchisio P., Clerici-Schoeller M.A., Wigzell H., Fenyo E.M., Albert J., Uhlen M., et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(5):1721-1725.
36. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 2003, 422(6929):307-312.
37. West J.T., Weldon S.K., Wyss S., Lin X., Yu Q., Thali M., Hunter E. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation. J. Virol. 2002, 76(7):3338-3349.
38. Wolinsky S.M., Wike C.M., Korber B.T., Hutto C., Parks W.P., Rosenblum L.L., Kunstman K.J., Furtado M.R., Munoz J.L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255(5048):1134-1137.
39. Wu X., Parast A.B., Richardson B.A., Nduati R., John-Stewart G., Mbori-Ngacha D., Rainwater S.M., Overbaugh J. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J. Virol. 2006, 80(2):835-844.
40. Zhang H., Orti G., Du Q., He J., Kankasa C., Bhat G., Wood C. Phylogenetic and phenotypic analysis of HIV type 1 env gp120 in cases of subtype C mother-to-child transmission. AIDS Res. Hum. Retrovir. 2002, 18(18):1415-1423.
41. Zhang H., Hoffmann F., He J., He X., Kankasa C., Ruprecht R., West J.T., Orti G., Wood C. Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology 2005, 2:67.
42. Zhang H., Hoffmann F., He J., He X., Kankasa C., West J.T., Mitchell C.D., Ruprecht R.M., Orti G., Wood C. Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology 2006, 3:73.